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Background: Critical limb ischemia (CLI) is a terminal stage of peripheral arterial disease (PAD), in the absence 
of intervention, may lead to lower extremity amputation or death. In cases where medical management is not 
effective or severe cases of PAD, endovascular and surgical interventions are indicated. Endovascular interven-
tions have become the first-line approach of CLI management and advanced considerably within the past decade.
Case Description: A smoker hypertensive 73-years old female complained left leg pain accompanied with necrotic 
wound since 6 months ago. Duplex ultrasound showed no-flow from proximal to distal left superficial femoral 
artery (SFA). CT-Angiography showed total occlusion from proximal left SFA to proximal popliteal artery about 
7,2 cm in length with collateral vessels. She was diagnosed with CLI left inferior extremity Fontaine IV Rutherford 
5. Angiography also confirmed the total occlusion from proximal to distal left SFA with collateral vessels. A 
6mmx100mmx120cm self-expanding stent deployed at proximal-mid SFA. The patient showed clinically 
improvement and discharged on the day 5 observation
Conclusion: Favorable result could be achieved by endovascular stenting approach in patients with CLI, where 
close follow-up treatment afterward could save limb loss.
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 Peripheral arterial disease (PAD) is defined as a process of 
atherosclerosis that occurs in arteries from the distal arteries to aortic 
bifurcation with or without symptoms.1 Atherosclerosis is the most 
common cause of Critical Limb Ischemia (CLI) with the incidence 
reaching 4% of the population over 40 years-old. CLI is characterized by 
ischemic pain at rest or gangrene caused by occlusive artery disease for 
more than 2 weeks.2,3 
 The prevalence of amputation and death increased every 
year, aggressive therapy and immediate revascularization were needed 
to restore blood flow to the injured area.4,5 For CLI patients without 
revascularization, they usually ended up with an amputation. Open 
revascularization has slowly been replaced by endovascular interven-
tion in the last two decades. The advantages of endovascular percutane-
ous procedures included could be done under local anesthesia, the 
better healing of incision wounds, earlier recovery, and easier reinter-
vention when was required.5,6
2. Case Presentation
 A 73-years old female complained of left leg pain since 6 
months ago. Amputation was performed 4 months ago on the digit V 
left leg due to infection wound. Complaints of the left leg aching like 
sliced-up appeared since last 2 months prior to admission, especially 
when resting at night and more comfortable with the left leg on hanging 
position. History of hypertension since 5 years ago, smoking 2 packs/-
day for last 50 years.
 Physical examination showed blood pressure 140/90mmHg, 
regular heart rate 97 beats/minute, respiratory rate 18 times/minute, 
and oxygen saturation of 98% with room air. Examination of the head, 
neck, and abdomen were within normal limits, while thorax showed a 
shifting in ictus cordis to intercostal-space VI left midclavicula-line. 
Electrocardiography suggested sinus tachycardia, heart rate of 103 
beats/minutes with LVH. Laboratory tests showed an increase in 
leukocytes to 14,200 103/mcL, while others within normal limits.
 Vascular examination of the left inferior limb found blacken-
ing wound 11x7 cm in size on the back of the left foot, decreased
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pulsation starting from left common femoral artery till popliteal artery 
(+1) and pulseless from the tibialis anterior artery to distal part (Figure 
1). There was no muscle atrophy, motor impairment, but a decrease of 
sensory response around the wound was observed. Right ankle-brachial 
index (ABI) was 0.9 while the left one was immeasurable. From the 
clinical stage of the lower extremity, this patient was classified as 
Fontaine stage IV, Rutherford category 5.
Figure 1. Blackening wound at left foot
 Duplex ultrasound (DUS) examination for left leg showed 
monophasic spectral doppler at the common femoral artery (CFA), 
profundus femoral artery (PFA), popliteal artery levels. No flow in the 
proximal to distal of the superficial femoral artery (SFA) and no flow 
from tibialis anterior artery to distal were observed. CT-angiography 
was performed with result suggested a total occlusion of left SFA 1/3 of 
distal to the proximal side of popliteal artery 7.2cm in length with 
surrounding collaterals. The moderate stenosis of the SFA 1/3 of the 
middle with collaterals was shown as seen in Figure 2.
 The patient was performed arteriography of the left inferior 
extremity that showed stenosis 60% in external Iliac artery, multiple 
stenosis with maximal stenosis 70% in the CFA, total occlusion from 
proximal to distal SFA, 80% stenosis in the PFA. The popliteal artery to 
distal of the left leg was not evaluated.
Figure 2. (A) Duplex Ultrasounds for left inferior extremity that showed 
no flow at SFA; (B) CT Angiography of bilateral inferior extrimities.
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 We decided to revascularize by opening up the left CFA 
stenosis and total occlusion of SFA. The lesion was treated with a 
5.0x100 mm drug-coated balloon (DCB) inflation in the proximal-mid 
SFA by applying pressure of 10atm for 2 minutes. Cineangiograph-
ic-evaluation showed TIMI 1 flow to the distal left SFA  and dissection  
was found at proximal left SFA. A 6mm x 100mm x 120cm self expand-
ing stent was deployed from proximal to mid left SFA resulting in TIMI 
flow 2 to the distal part (Figure 3). The anticoagulant then adminis-
tered to gain a better flow.
Figure 3. (A) Angiography of left inferior extremity that showed total 
occlusion at SFA with collateral vessel; (B) Deploying Self Expanding 
Stent in superficialis femoral artery
  The clinical evaluation showed an improvement as shown by 
reduction of leg pain. The pulsation of left dorsal pedis artery also 
improved (+1) but still weak, the ABI score was 0,3. DUS examination 
showed the blood flow in the left inferior limb filling the left superficial 
femoral artery through a stent that reached to the left popliteal artery. 
The patient went home with dual antiplatelet and oral anticoagulant for 
a certain period until the next flow evaluation was performed. 
3. Discussion
 Epidemiology of PAD was reported from several studies in 
various European countries. TASC II study noted that 5-10% of asymp-
tomatic PAD.1,4 In most asymptomatic PAD, the diagnosis is made on 
clinical examination (arterial pulses) or from the ABI score. The 
symptomatic PAD obtained in the form of typical clinical picture of 
intermittent claudication are pain in the thigh increases when walking 
and disappears at rest. PAD patients with claudication would be
suffered from CLI within the next 5 years.4 CLI is characterized by 
chronic conditions (more than 2 weeks) ischemic rest pain, wounds or 
ulcer that does not heal, or gangrene in one or both legs that have been 
objectively proven to have occlusion in the arteries.1,2,8
 Several noninvasive examinations helpful in diagnosis PAD 
including ABI score, duplex ultrasound, and ultrasound CW Doppler. 
ABI is an easy and inexpensive examination but had a sensitivity, 
specificity approaching the gold-standard diagnostic for PAD. ABI value 
<0.90 is an indicator of the presence of significant stenosis lesions. 
Based on clinical condition and ABI score, we can predict the prognosis 
of CLI according to the Society for Vascular Surgery Lower Extremity 
Threatened Limb (SVS WifI) Classification System (Figure 4).1,11
 The revascularization strategy must consider of anatomic, 
comorbid compatibility, availability of resources, operator expertise, 
and patient preferences.1,9 This patient was sufferred from CLI with 
Fontaine classification stage IV and Rutherford category 5, with WIFi 
score 7, which was considered to  a high-risk for amputation. From the 
examination we found that there was sufficient flow to the distal, 
therefore revascularization of occluded SFA expected could improve 
distal flow and revascularized the distal tissues. According to the 2017 
ESC Guideline for PAD, endovascular strategy for femoropopliteal 
occlusive lesion was class-I recommendations (Figure 5) in this case, an 
elderly with risk factor heart failure and hypertension with short 
occlusion at SFA, where revascularization strategy more recommended 
for endovascular than surgery. 
 Several factors are predicted that could affect the patency of 
action PTA include: (1) the nature and severity of lesions, (2) the 
anatomy of the affected limb, (3) clinical manifestations of the extremi-
ties, (4) systemic factors such as DM or smoker.9,11 She had a short 
occlusion of less than 25 cm, the guideline suggested class IIB recom-
mendation of the drug-eluting balloon or drug-eluting stent  revascular-
ization strategy with an DCB inflation, unfortunelty the slow flow 
observed to distal part and accompanied by dissection at SFA. 
 
 The objective of endovascular stenting is to improve the 
conditions of primary insufficiency such as residual stenosis and 
extensive recoil flow. Stenting also minimizes the risk of dissection and 
improves long-term patency.1,3,7 Comparing to other endovascular 
procedures, stenting provides effective results with patency within 3 
years reaching to 88%, besides that it rarely occurs acute or subacute 
occlusion. However, stent fracture could occur resulting in restenosis or 
thrombosis.7,8 In the case presented above, self-expanding stent was 
implanted  from proximal-mid of left SFA to reserve the flow caused by 
dissection resulting in TIMI 1-2 flow  to the distal. The clinical evalua-
tion showed symptom improvement including leg pain was subsided, 
pulsation of left dorsal pedis artery improved and ABI score become 0,3.
 Based on the International Society for Cardiovascular 
Surgery (ISCVS), the success of revascularization is assessed by 
anatomy, hemodynamics, and clinics, as follows: (i) technically success-
ful if there is <30% residual stenosis (anatomy) (ii) increase in ABI 
value >0.10 is compared before the procedure (hemodynamics) (iii) 
improvement of at least 1 clinical symptom (clinics).4,9,11 In this case the 
procedure fulfilled the revascularization success criteria since she 
improved clinically, ABI and the anatomy.
32
(A) (B)
M.R. Ramadhan, et al. Heart Sci J 2020; 1(1): 30-34
4. Conclusion
 
 It has been reported case of a hypertensive smoker 73 
years-old female presenting with clinically Fontaine IV Rutherfords 5 
caused by a total occlusion of SFA. The installation of self-expending 
percutaneous stent showed a good result a shown by the clinical 
improvement and ABI score. This case suggested that an appropriate 
revascularization strategy and good management after revasculariza-
tion are very important in saving extremities in CLI patients.
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Recommendations on revascularization of femoro-popliteal occlusive lesionsc
Recommendations Classa Levelb
An endovascular-first strategy is recommended in short (i.e. <25 cm) lesions.302,303 I C
Primary stent implantation should be considered in short (i.e. <25 cm) lesions.304, 305 IIa A
Drug-eluting balloons may be considered in short (i.e. <25 cm) lesions.77,306–310 IIb A
Drug-eluting stents may be considered for short (i.e. <25 cm) lesions.302,303,311 IIb B
Drug-eluting balloons may be considered for the treatment of in-stent restenosis.312,313 IIb B
In patients who are not at high risk for surgery, bypass surgery is indicated for long (i.e. >_25 cm) superficial femoral artery lesions
when an autologous vein is available and life expectancy is > 2 years.314
I B
The autologous saphenous vein is the conduit of choice for femoro-popliteal bypass.284,315 I A
When above-the-knee bypass is indicated, the use of a prosthetic conduit should be considered in the absence of any autologous
saphenous vein.284
IIa A
In patients unfit for surgery, endovascular therapy may be considered in long (i.e. >_25 cm) femoro-popliteal lesions.312 IIb C
aClass of recommendation.
bLevel of evidence.
cThese recommendations apply for patients with intermittent claudication and severe chronic limb ischaemia.
Figure 4. Clasification System Society for Vascular Surgery Lower Extremty Threatened Limb (SVS WifI)1
Figure 5. Recommendation on revascularization of femoro-popliteal occlusive lession1
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